Jeffrey G. Marx

Jeffrey Marx serves as Chief Scientific Officer with some two decades of experience in executive management with medical device companies. He brings considerable expertise in research & development, commercialization, sales management, business development, and strategic planning. His experience includes over 13 years with Orthovita, where he was VP of Corporate Development. When Orthovita was acquired by Stryker Orthobiologics, Jeff led the team that integrated the two companies; he continued as VP of Corporate Development at Stryker. He has earned a Ph.D. in Ceramic Engineering from Missouri University of Science and Technology, Rolla MO.